Pulse lineResearch With Heart Logo

ARIC Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Moorthy S, Cheung N, Klein R, Shahar E, Wong TY. "Are lung disease and function related to age-related macular degeneration?" Am J Ophthalmol. 2011;151(2):375-9.
Gross AL, Power MC, Albert MS, et al. "Application of Latent Variable Methods to the Study of Cognitive Decline When Tests Change over Time." Epidemiology. 2015;26(6):878-87.
Selvaraj S, Myhre PL, Vaduganathan M, et al. "Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community." JACC Heart Fail. 2020;8(8):640-653.
Ndumele CE, Matsushita K, Astor B, et al. "Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study." Eur J Prev Cardiol. 2014;21(7):866-75.
Shachter NS. "Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism." Curr Opin Lipidol. 2001;12(3):297-304.
Volcik KA, Barkley R A, Hutchinson RG, et al. "Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants." Am J Epidemiol. 2006;164(4):342-8.
Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W. "Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations." Am J Hum Genet. 1994;54(2):341-60.
Selvaraj S, Claggett B, Johansen MC, et al. "Apolipoprotein E Polymorphism, Cardiac Remodeling, and Heart Failure in the ARIC Study." J Card Fail. 2022;28(7):1128-1136.
Surguchov AP, Boerwinkle E, Sharett AR, Patsch WP. "Apolipoprotein E genotype and lipid transport: insight into the role of the epsilon 4 allele." Atherosclerosis. 1994;106(1):119-21.
Sturgeon JD, Folsom AR, Bray MS, Boerwinkle E, Ballantyne CM. "Apolipoprotein E genotype and incident ischemic stroke: the Atherosclerosis Risk in Communities Study." Stroke. 2005;36(11):2484-6.
Boland LL, Folsom AR, Boerwinkle E. "Apolipoprotein E genotype and gallbladder disease risk in a large population-based cohort." Ann Epidemiol. 2006;16(10):763-9.
Liew G, Shankar A, Wang J J, et al. "Apolipoprotein E gene polymorphisms and retinal vascular signs: the atherosclerosis risk in communities (ARIC) study." Arch Ophthalmol. 2007;125(6):813-8.
Wong T Y, Shankar A, Klein R, et al. "Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study." Ophthalmology. 2006;113(2):255-9.
Hsu CC, Kao LWH, Coresh J, et al. "Apolipoprotein E and progression of chronic kidney disease." JAMA. 2005;293(23):2892-9.
Foster MC, Coresh JJ, Fornage M, et al. "APOL1 variants associate with increased risk of CKD among African Americans." J Am Soc Nephrol. 2013;24(9):1484-91.
Klos K, Shimmin L, Ballantyne C, et al. "APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels." Hum Mol Genet. 2008;17(13):2039-46.
Maxwell TJ, Ballantyne CM, Cheverud JM, Guild CS, Ndumele CE. "APOE modulates the correlation between triglycerides, cholesterol, and CHD through pleiotropy, and gene-by-gene interactions." Genetics. 2013;195(4):1397-405.
Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E. "APOE genotype and cognitive decline in a middle-aged cohort." Neurology. 2005;64(2):268-76.
Pokharel Y, Mouhanna F, Nambi V, et al. "ApoB, small-dense LDL-C, Lp(a), LpPLA activity, and cognitive change." Neurology. 2019;92(22):e2580-e2593.
Stone K, Fryer S, Faulkner J, et al. "The aortic-femoral arterial stiffness gradient is blood pressure independent in older adults: the atherosclerosis risk in communities (ARIC) study." J Hypertens. 2021.
Stone K, Fryer S, Meyer ML, et al. "The aortic-femoral arterial stiffness gradient: an atherosclerosis risk in communities (ARIC) study." J Hypertens. 2021.
Wei J, Palta P, Meyer ML, et al. "Aortic Stiffness and White Matter Microstructural Integrity Assessed by Diffusion Tensor Imaging: The ARIC-NCS." J Am Heart Assoc. 2020;9(6):e014868.
Conlan MG, Folsom AR, Finch A, et al. "Antithrombin III: associations with age, race, sex and cardiovascular disease risk factors. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Thromb Haemost. 1994;72(4):551-6.
Ding J, Davis-Plourde KL, Sedaghat S, et al. "Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies." Lancet Neurol. 2020;19(1):61-70.
Federspiel JJ, Sueta CA, Kucharska-Newton AMaria, et al. "Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study." J Eval Clin Pract. 2018;24(1):48-55.
Iso H, Folsom AR, Koike KA, et al. "Antigens of tissue plasminogen activator and plasminogen activator inhibitor 1: correlates in nonsmoking Japanese and Caucasian men and women." Thromb Haemost. 1993;70(3):475-80.
Runchey SS, Folsom AR, Tsai MY, Cushman M, McGovern PD. "Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study." Br J Haematol. 2002;119(4):1005-10.
Kshirsagar AV, Offenbacher S, Moss KL, Barros SP, Beck JD. "Antibodies to periodontal organisms are associated with decreased kidney function. The Dental Atherosclerosis Risk In Communities study." Blood Purif. 2007;25(1):125-32.
Paskiewicz A, Wang FM, Yang C, et al. "Ankle-Brachial Index and Subsequent Risk of Severe Ischemic Leg Outcomes: The ARIC Study." J Am Heart Assoc. 2021;10(22):e021801.
Wang FM, Yang C, Ballew SH, et al. "Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: The Atherosclerosis Risk in Communities (ARIC) study." Atherosclerosis. 2021;336:39-47.
Matsushita K, Ballew SH, Sang Y, et al. "Ankle-brachial index and physical function in older individuals: The Atherosclerosis Risk in Communities (ARIC) study." Atherosclerosis. 2017;257:208-215.
Hua S, Loehr LR, Tanaka H, Heiss G, Coresh JJ, Selvin E. "Ankle-brachial index and incident diabetes mellitus: the atherosclerosis risk in communities (ARIC) study." Cardiovasc Diabetol. 2016;15(1):163.
Reich LM, Heiss G, Boland LL, Hirsch AT, Wu K, Folsom AR. "Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort." Vasc Med. 2007;12(4):267-73.
Tsai AW, Folsom AR, Rosamond WD, Jones DW. "Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study." Stroke. 2001;32(8):1721-4.
Kshirsagar AV, Coresh J, Brancati F, Colindres RE. "Ankle brachial index independently predicts early kidney disease." Ren Fail. 2004;26(4):433-43.
Stitziel NO, Khera AV, Wang X, et al. "ANGPTL3 Deficiency and Protection Against Coronary Artery Disease." J Am Coll Cardiol. 2017;69(16):2054-2063.
Arnett DK, Borecki IB, Ludwig EH, et al. "Angiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: the atherosclerosis risk in communities and the NHLBI family heart studies." Atherosclerosis. 1998;138(1):111-6.
Golden S H, Williams JE, Ford DE, et al. "Anger temperament is modestly associated with the risk of type 2 diabetes mellitus: the Atheroslcerosis Risk in Communities Study." Psychoneuroendocrinology. 2006;31(3):325-32.
Williams JE, Paton CC, Siegler IC, Eigenbrodt ML, Nieto FJ, Tyroler HA. "Anger proneness predicts coronary heart disease risk: prospective analysis from the atherosclerosis risk in communities (ARIC) study." Circulation. 2000;101(17):2034-9.
Kucharska-Newton AMaria, Williams JE, Chang PP, Stearns SC, Sueta CA, Blecker SB. "Anger proneness, gender, and the risk of heart failure." J Card Fail. 2014;20(12):1020-6.
McAdams-Demarco MA, Maynard JW, Coresh J, Baer AN. "Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study." Arthritis Res Ther. 2012;14(4):R193.
Yeap BBeng, Marriott RJames, Adams RJ, et al. "Androgens In Men Study (AIMS): protocol for meta-analyses of individual participant data investigating associations of androgens with health outcomes in men." BMJ Open. 2020;10(5):e034777.
Li M, Li Y, Weeks O, et al. " and Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function." J Am Soc Nephrol. 2017;28(3):981-994.
Böger CA, Gorski M, McMahon GM, et al. " and Loci Associate with Plasma Osmolality." J Am Soc Nephrol. 2017;28(8):2311-2321.
Ma Y, Jun GR, Zhang X, et al. "Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype." JAMA Neurol. 2019.
Direk N, Williams S, Smith JA, et al. "An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype." Biol Psychiatry. 2017;82(5):322-329.
Tao R, Zeng D, Franceschini N, North KE, Boerwinkle E. "Analysis of Sequence Data Under Multivariate Trait-Dependent Sampling." J Am Stat Assoc. 2015;110(510):560-572.
Nandakumar P, Lee D, Hoffmann TJ, et al. "Analysis of putative cis-regulatory elements regulating blood pressure variation." Hum Mol Genet. 2020;29(11):1922-1932.
Carty CL, Bhattacharjee S, Haessler J, et al. "Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study." Circ Cardiovasc Genet. 2014;7(4):505-13.
Li AH, Morrison AC, Kovar C, et al. "Analysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease." Nat Genet. 2015;47(6):640-2.
Chambless LE, Davis V. "Analysis of associations with change in a multivariate outcome variable when baseline is subject to measurement error." Stat Med. 2003;22(7):1041-67.
Fu W, O'Connor TD, Jun G, et al. "Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants." Nature. 2013;493(7431):216-20.
Brody JA, Morrison AC, Bis JC, et al. "Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology." Nat Genet. 2017;49(11):1560-1563.
Charles BA, Hsieh MM, Adeyemo AA, et al. "Analyses of genome wide association data, cytokines, and gene expression in African-Americans with benign ethnic neutropenia." PLoS One. 2018;13(3):e0194400.
C Quarta C, Buxbaum JN, Shah AM, et al. "The amyloidogenic V122I transthyretin variant in elderly black Americans." N Engl J Med. 2015;372(1):21-9.
Hasbani NR, Ligthart S, Brown MR, et al. "American Heart Association's Life's Simple 7: Lifestyle Recommendations, Polygenic Risk, and Lifetime Risk of Coronary Heart Disease." Circulation. 2022;145(11):808-818.
Folsom AR, Shah AM, Lutsey PL, et al. "American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function." Am J Med. 2015;128(9):970-6.e2.
Mok Y, Sang Y, Ballew SH, et al. "American Heart Association's Life's Simple 7 at Middle Age and Prognosis After Myocardial Infarction in Later Life." J Am Heart Assoc. 2018;7(4).
Folsom AR, Olson NC, Lutsey PL, Roetker NS. "American Heart Association's Life's Simple 7 and incidence of venous thromboembolism." Am J Hematol. 2015;90(5):E92.
Garg PK, O'Neal WT, Chen LYee, Loehr LR, Sotoodehnia N, Soliman EZ. "American Heart Association's Life Simple 7 and Risk of Atrial Fibrillation in a Population Without Known Cardiovascular Disease: The ARIC (Atherosclerosis Risk in Communities) Study." J Am Heart Assoc. 2018;7(8).
Rooney MR, Tang O, Tcheugui JBEchouffo, et al. "American Diabetes Association Framework for Glycemic Control in Older Adults: Implications for Risk of Hospitalization and Mortality." Diabetes Care. 2021.
Beecham GW, Bis JC, Martin ER, et al. "The Alzheimer's Disease Sequencing Project: Study design and sample selection." Neurol Genet. 2017;3(5):e194.
Juraschek SP, Steffes MW, Miller ER, Selvin E. "Alternative markers of hyperglycemia and risk of diabetes." Diabetes Care. 2012;35(11):2265-70.
Raffield LM, Iyengar AK, Wang B, et al. "Allelic Heterogeneity at the CRP Locus Identified by Whole-Genome Sequencing in Multi-ancestry Cohorts." Am J Hum Genet. 2020;106(1):112-120.
Palmer ND, Kahali B, Kuppa A, et al. "Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction." Hum Mol Genet. 2021;30(15):1443-1456.
Ding J, Eigenbrodt ML, Mosley TH, et al. "Alcohol intake and cerebral abnormalities on magnetic resonance imaging in a community-based population of middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2004;35(1):16-21.
Eigenbrodt ML, Mosley TH, Hutchinson RG, Watson RL, Chambless LE, Szklo M. "Alcohol consumption with age: a cross-sectional and longitudinal study of the Atherosclerosis Risk in Communities (ARIC) study, 1987-1995." Am J Epidemiol. 2001;153(11):1102-11.
Demirovic J, Nabulsi A, Folsom AR, et al. "Alcohol consumption and ultrasonographically assessed carotid artery wall thickness and distensibility. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Circulation. 1993;88(6):2787-93.
Kao WH, Puddey IB, Boland LL, Watson RL, Brancati FL. "Alcohol consumption and the risk of type 2 diabetes mellitus: atherosclerosis risk in communities study." Am J Epidemiol. 2001;154(8):748-57.
Fuchs FD, Chambless LE, Whelton PK, Nieto FJ, Heiss G. "Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study." Hypertension. 2001;37(5):1242-50.
Daya NR, Rebholz CM, Appel LJ, Selvin E. "Alcohol Consumption and Risk of Hospitalizations and Mortality in the Atherosclerosis Risk in Communities Study." Alcohol Clin Exp Res. 2020;44(8):1646-1657.
Gonçalves A, Claggett B, Jhund PS, et al. "Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study." Eur Heart J. 2015;36(15):939-45.
Hu EA, Lazo M, Rosenberg SD, Grams ME, Steffen LM, Coresh JJ. "Alcohol Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities Study." J Ren Nutr. 2020;30(1):22-30.
He X, Rebholz CM, Daya N, Lazo M. "Alcohol consumption and incident diabetes: The Atherosclerosis Risk in Communities (ARIC) study." Diabetologia. 2019;62(5):770-778.
Lazo M, Chen Y, McEvoy JW, et al. "Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study." Clin Chem. 2016;62(9):1202-10.
Oelsner EC, Balte PP, Grams ME, et al. "Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study." Am J Respir Crit Care Med. 2019;199(3):321-332.
Mok Y, Ballew SH, Sang Y, Coresh JJ, Joshu CE, Platz EA. "Albuminuria, Kidney Function, and Cancer Risk in the Community." Am J Epidemiol. 2020;189(9):942-950.
Mok Y, Ballew SH, Stacey RBrandon, et al. "Albuminuria and Prognosis Among Individuals With Atherosclerotic Cardiovascular Disease: The ARIC Study." J Am Coll Cardiol. 2021;78(1):87-89.
Grams ME, Astor BC, Bash LD, Matsushita K, Wang Y, Coresh J. "Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury." J Am Soc Nephrol. 2010;21(10):1757-64.
Scheppach JB, Coresh JJ, Wu A, et al. "Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study." Am J Kidney Dis. 2020;76(6):775-783.

Pages